Complete Story


U.S. Government to Provide $11 Million for Production of Monkeypox Vaccine

The production is expected to begin later this year

The U.S. government said on Monday it would provide about $11 million to support the packaging of Bavarian Nordic's (BAVA.CO) Jynneos monkeypox vaccine at a U.S.-based manufacturer's facility.

The Danish company, which is the maker of the only approved monkeypox vaccine, had earlier this month signed up Michigan-based Grand River Aseptic Manufacturing to package the two-dose shot.

The production is expected to begin later this year, the U.S. Department of Health and Human Services said, adding that the funding will help the manufacturer recruit more staff and buy additional equipment.

Please select this link to read the complete article from Reuters.

Printer-Friendly Version